DARA BioSciences, Inc. (DARA)

[ARBITRARY & CAPRICIOUS]

Here's the 120 day chart. Basically you can drive a stake in the ground that the review will be done by 120 days...Almost 100%....let's see.......and hope their advisors had the targeted subset right as there are doubts their population(,200,000 prevalence) is too large to qualify...

http://www.accessdata.fda.gov/FDATrack/track?program=osmp&id=OSMP-OOPD-Percentage-orphan-drug-designation-reviewed-completed-in-120-days-or-less